Home Cart Sign in  
Chemical Structure| 17673-25-5 Chemical Structure| 17673-25-5

Structure of Phorbol
CAS No.: 17673-25-5

Chemical Structure| 17673-25-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phorbol is a highly toxic diterpene, and it's esters have important biological properties.

Synonyms: 4β-Phorbol; NSC 154778; (+)-Phorbol

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phorbol

CAS No. :17673-25-5
Formula : C20H28O6
M.W : 364.43
SMILES Code : O[C@]1([C@@H](C1(C)C)[C@@]([H])([C@@]([C@@]([H])([C@@]2(C3)O)C=C(C2=O)C)([C@@H]4C)O)C=C3CO)[C@@H]4O
Synonyms :
4β-Phorbol; NSC 154778; (+)-Phorbol
MDL No. :MFCD00065450
InChI Key :QGVLYPPODPLXMB-UBTYZVCOSA-N
Pubchem ID :442070

Safety of Phorbol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01195272 Rheumatoid Arthritis Phase 4 Completed - United Kingdom ... More >> Liverpool, United Kingdom, L9 7AL Less <<
NCT03448250 Breast Cancer Not Applicable Recruiting March 2020 Germany ... More >> Technical University of Dortmund, Leibniz Research Centre for Working Environment and Human Factors Recruiting Dortmund, Germany, 44139 Contact: Carsten Watzl, PhD    +492311084233    watzl@ifado.de    University Medical Center Leipzig, Department of Medical Psychology and Medical Sociology, Section Psychosocial Oncology Active, not recruiting Leipzig, Germany, 04103 Less <<
NCT02137876 - Withdrawn(Subject recruitment ... More >>was unsuccessful.) Less << - United States, Illinois ... More >> Northwestern University Comprehensive Transplant Center Chicago, Illinois, United States, 60611 Less <<
NCT01850459 - Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT01357070 Healthy Volunteers Not Applicable Completed - United Kingdom ... More >> Cardiovascular Medicine Research Unit, Hammersmith Hospital London, United Kingdom, W12 0NN Less <<
NCT00551746 Cardiovascular Disease Not Applicable Completed - United States, Utah ... More >> Intermountain Medical Center Murray, Utah, United States, 84157 Less <<
NCT00364715 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00551746 - Completed - -
NCT01195272 - Completed - -
NCT01795924 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Phase 2 Terminated(Difficulty of patie... More >>nt enrollment) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 United States, Kentucky University of Kentucky Medical Center Lexington, Kentucky, United States, 40513 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.74mL

0.55mL

0.27mL

13.72mL

2.74mL

1.37mL

27.44mL

5.49mL

2.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories